This document summarizes a study on the drug prednisone. It provides information on the generic and brand names, classification, mode of action, dosing, indications, contraindications, side effects, adverse effects, drug interactions, nursing responsibilities, and references for prednisone. The study was presented to the Faculty of Nursing Department to fulfill requirements for a pediatric nursing rotation.
This document summarizes a study on the drug prednisone. It provides information on the generic and brand names, classification, mode of action, dosing, indications, contraindications, side effects, adverse effects, drug interactions, nursing responsibilities, and references for prednisone. The study was presented to the Faculty of Nursing Department to fulfill requirements for a pediatric nursing rotation.
This document summarizes a study on the drug prednisone. It provides information on the generic and brand names, classification, mode of action, dosing, indications, contraindications, side effects, adverse effects, drug interactions, nursing responsibilities, and references for prednisone. The study was presented to the Faculty of Nursing Department to fulfill requirements for a pediatric nursing rotation.
This document summarizes a study on the drug prednisone. It provides information on the generic and brand names, classification, mode of action, dosing, indications, contraindications, side effects, adverse effects, drug interactions, nursing responsibilities, and references for prednisone. The study was presented to the Faculty of Nursing Department to fulfill requirements for a pediatric nursing rotation.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 5
A Drug Study on Prednisone
A Drug Study Presented to
The Faculty of Nursing Department
Mrs. Josephine B. Magno, RN, MN
In Partial Fulfillment on the
Requirements in NCM 209
Pediatric Nursing Rotation
By:
Princess Alane Marie T. Moreno, St.N
BSN 2H
March 28, 2020
Generic Name: predniSONE Brand Name: Apo-PredniSONE, PredniSONE Intensol Classification: Pharmacotherapeutic: Adrenal corticosteroid Clinical: Anti-inflammatory, immunosuppressant. Mode of Action: Inhibits accumulation of inflammatory cells at inflammation sites, phagocytosis, lysosomal enzyme release/synthesis, release of mediators of inflammation. Dose and Route: PO: ADULTS, ELDERLY: 5–60 mg/day in divided doses. CHILDREN: 0.05–2 mg/kg/ day in 1–4 divided doses. Indication: Dose dependent upon condition treated, patient response rather than rigid adherence to age, weight, or body surface area. Contraindication: Prednisone tablets are contraindicated in systemic fungal infections and known hypersensitivity to components. Side Effects: Frequent: Insomnia, heartburn, nervousness, abdominal distention, diaphoresis, acne, mood swings, increased appetite, facial flushing, delayed wound healing, increased susceptibility to infection, diarrhea, and constipation. Occasional: Headache, edema, change in skin color, frequent urination. Rare: Tachycardia, allergic reaction (rash, urticaria), psychological changes, hallucinations, depression. Adverse Effects: CNS: headache,nervousness,depression,euphoria,personality changes, psychosis,vertigo,paresthesia,insomnia,restlessness,seizures,meningitis, increased intracranial pressure CV: hypotension, hypertension, vasculitis, heart failure, thrombophlebitis, thromboembolism, fat embolism, arrhythmias, shock EENT: posterior subcapsular cataracts (especially in children), glaucoma, nasal irritation and congestion, rebound congestion, sneezing, epistaxis, nasopharyngeal and oropharyngeal fungal infections, perforated nasal septum, anosmia, dysphonia, hoarseness, throat irritation (all with longterm use) GI: nausea, vomiting, abdominal distention, rectal bleeding, esophageal candidiasis, dry mouth, esophageal ulcer, pancreatitis, peptic ulcer GU: amenorrhea, irregular menses Hematologic: purpura Metabolic: sodium and fluid retention, hypokalemia, hypocalcemia, hyperglycemia, decreased carbohydrate tolerance, diabetes mellitus, growth retardation (in children), cushingoid effects (with long-term use), hypothalamicpituitary-adrenal suppression (with systemic use longer than 5 days), adrenal suppression (with high-dose, longterm use) Musculoskeletal: muscle weakness or atrophy, myalgia, myopathy, osteoporosis, aseptic joint necrosis, spontaneous fractures (with long-term use), osteonecrosis, tendon rupture Respiratory: cough, wheezing, bronchospasm Skin: rash, pruritus, contact dermatitis, acne, striae, poor wound healing, hirsutism, thin fragile skin, petechiae, bruising, subcutaneous fat atrophy, urticaria, angioedema Other: bad taste, increased or decreased appetite, weight gain (with long-term use), facial edema, aggravation or masking of infections, hypersensitivity reaction Drug Interaction: Drug-drug. Amphotericin B, mezlocillin, piperacillin, thiazide and loop diuretics, ticarcillin: additive hypokalemia Aspirin, other nonsteroidal anti-inflammatory drugs: increased risk of GI discomfort and bleeding Cardiac glycosides: increased risk of digitalis toxicity due to hypokalemia Cyclosporine: therapeutic benefits in organ transplant recipients, but with increased risk of toxicity Erythromycin, indinavir, itraconazole, ketoconazole,ritonavir,saquinavir: increased prednisone blood level and effects Hormonal contraceptives: impaired metabolism and increased effects of prednisone Isoniazid: decreased isoniazid blood level Live-virus vaccines: decreased antibody response to vaccine, increase risk of adverse effects Oral anticoagulants: reduced anticoagulant requirements, opposition to anticoagulant action Phenobarbital, phenytoin, rifampin: decreased prednisone efficacy Salicylates: reduced salicylate blood level Somatrem: inhibition of somatrem’s growth- promoting effects Theophylline: altered pharmacologic effects of either drug Drug-diagnostic tests. Calcium, potassium, thyroid 131I uptake, thyroxine, triiodothyronine: decreased levels Cholesterol, glucose: increased levels Nitroblue tetrazolium test for bacterial infection: false-negative result Drug-herbs. Alfalfa: activation of quiescent systemic lupus erythematosus Echinacea: increased immune-stimulating effects Ephedra (ma huang): decreased drug blood level Ginseng: potentiation of immunomodulating effect Licorice: prolonged drug activity Drug-behaviors. Alcohol use: increased risk of gastric irritation and GI ulcers Nursing Responsibility:
Obtain baselines for height, weight, B/P, serum glucose, electrolytes.
Check results of initial tests (tuberculosis [TB] skin test, X-rays, EKG). Monitor B/P,serum electrolytes, glucose, results of bone mineral density test, height, weight in children. Be alert to infection (sore throat, fever, vague symptoms); assess oral cavity daily for signs of Candida infection. Monitor for symptoms of adrenal insufficiency, or immunosuppression. Report if there is fever, sore throat, muscle aches, sudden weight gain, swelling, loss of appetite, or fatigue. Avoidalcohol, minimize use of caffeine. Maintain fastidious oral hygiene. Do not abruptly discontinue without physician’s approval. Avoidexposure to chickenpox, measles. Long-term use may significantly increase risk of serious infections. References: Kizior, R.J., Hodgson, B.B., Hodgson, K.J, & Witmer, J.B. (2016). Saunders nursing drug handbook 2019. St. Louis, MO: Elsevier Kizior, R.J., & Hodgson, K.J. (2019). Saunders nursing drug handbook 2019. St. Louis, MO: Elsevier Prednisone (Prednisone Tablets, USP): Uses, Dosage, Side Effects, Interactions, Warning. (2019, October 24). Retrieved from https://www.rxlist.com/prednisone- drug.htm#clinpharm S